Literature DB >> 212181

A new in vitro cell line established from human large cell variant of oat cell lung cancer.

E R Fisher, J D Paulson.   

Abstract

A new tissue culture cell line, SHP-77, has been established from explant cultures of a primary human lung cancer. Although the latter exhibited histological features of the so-called large or polygonal cell undifferentiated variant, neurosecretory granules were detected ultrastructurally in cells of the original tumor, culture line, and neoplasms developing after transplantation of the latter in nude mice. These features attest to the identity of the original tumor as a large-cell variant of oat cell cancer. In addition, electron microscopy revealed the presence of gland formation and intracytoplasmic lamellar bodies in the cells of SHP-77. This information indicates the potential for varied differentiation and morphological expression of so-called undifferentiated lung cancer cells and is pertinent to nosological considerations concerning human lung cancer. The cell line has maintained its morphological, karyotypic, chromosomal, and growth characteristics after transplantation to nude mice. Because of this stability, SHP-77 appears to represent a propitious cell line for in vitro and in vivo biological and therapeutic studies of this type of lung cancer.

Entities:  

Mesh:

Year:  1978        PMID: 212181

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Reversal of anticancer multidrug resistance by the ardeemins.

Authors:  T C Chou; K M Depew; Y H Zheng; M L Safer; D Chan; B Helfrich; D Zatorska; A Zatorski; W Bornmann; S J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

2.  Establishment, growth properties, and morphological characteristics of permanent human small cell lung cancer cell lines.

Authors:  G Bepler; G Jaques; K Neumann; G Aumüller; C Gropp; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

3.  Interferon gamma and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentiation in small-cell lung cancer cell lines.

Authors:  M R Ruff; W L Farrar; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  Activation of the protein-tyrosine kinase associated with the bombesin receptor complex in small cell lung carcinomas.

Authors:  G Gaudino; D Cirillo; L Naldini; P Rossino; P M Comoglio
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Establishment and characterization of a novel highly malignant lung cancer cell line ZX2021H derived from a metastatic lymph node lesion.

Authors:  Lingling Zu; Xuebing Li; Jinling He; Ning Zhou; Fanrong Meng; Xiaozhou Li; Song Xu; Lei Zhang
Journal:  Thorac Cancer       Date:  2022-03-16       Impact factor: 3.223

6.  Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models.

Authors:  Danlin Sun; Anna S Nikonova; Peishan Zhang; Alexander Y Deneka; Mark E Fitzgerald; Ryan E Michael; Linda Lee; Anna C Lilly; Stewart L Fisher; Andrew J Phillips; Christopher G Nasveschuk; David A Proia; Zhigang Tu; Erica A Golemis
Journal:  Mol Cancer Ther       Date:  2021-05-27       Impact factor: 6.261

7.  Chemosensitivity testing of small cell lung cancer using the MTT assay.

Authors:  B G Campling; J Pym; H M Baker; S P Cole; Y M Lam
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

8.  Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?

Authors:  B G Campling; K Baer; H M Baker; Y M Lam; S P Cole
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.